Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT06055816. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Cancer
ClinicalTrials.gov study NCT00947102. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00055757. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Docetaxel, Gemcitabine and Pazopanib as Treatment for Soft Tissue Sarcoma
ClinicalTrials.gov study NCT01719302. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial of YL-13027 in Combination With Gemcitabine and Nab-paclitaxel in Patients With Refractory Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT06199466. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder
ClinicalTrials.gov study NCT02202772. IPD Sharing: NO. Countries: 1. Publications: 0.
Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride
ClinicalTrials.gov study NCT00981162. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ph 1 Study of VS-4718, a FAK Inhibitor, in Combination With Nab-paclitaxel and Gemcitabine in Advanced Cancer Subjects
ClinicalTrials.gov study NCT02651727. IPD Sharing: NO. Countries: 1. Publications: 0.
A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer
ClinicalTrials.gov study NCT00191490. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Ref
ClinicalTrials.gov study NCT05634369. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Biweekly Gemcitabine and Docetaxel as First Line Treatment for Advanced Disease in Elderly Non-Small Cell Lung Cancer (NSCLC) Patients
ClinicalTrials.gov study NCT00905983. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer
ClinicalTrials.gov study NCT01191892. IPD Sharing: Not stated. Countries: 1. Publications: 0.
3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00077415. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLC
ClinicalTrials.gov study NCT07158489. IPD Sharing: NO. Countries: 1. Publications: 0.
Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
ClinicalTrials.gov study NCT03587662. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1-2, XIAP Antisense AEG35156 With Gemcitabine in Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT00557596. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Assess Safety of AZD7762 Administered Alone and in Combination With Gemcitabine in Patients With Advanced Solid Malignancies
ClinicalTrials.gov study NCT00413686. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Trial Comparing Gemcitabine and Carboplatin With and Without P276-00 in Subjects With Metastatic Triple Negative Breast Cancer, With a Run-in of Escalating Dose of P276-00 Added to Gemcitab
ClinicalTrials.gov study NCT01333137. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint
ClinicalTrials.gov study NCT00613730. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Safety and Effectiveness Study of CPI-613 and/or Gemcitabine to Treat Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT01830322. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.